MIAMI BEACH, FL—Pulmonary embolism (PE), an often-deadly condition that’s best served by a multidisciplinary approach to care, is the perfect target for artificial intelligence (AI), according to ...

HOLLYWOOD, FL—Growing interest in rapid-response teams to treat pulmonary embolism (PE), popularly known as PERTs, is tempered by the absence of firm numbers to support available therapies, ...

SAN FRANCISCO--(BUSINESS WIRE)--Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced new clinical data supporting advancements in pulmonary embolism ...

Pulmonary embolism (PE) is a common and potentially life-threatening condition with presentations ranging from mild symptoms to circulatory collapse. Early and accurate risk stratification is ...

The use of echocardiography, which creates two-dimensional images of the heart, can help clinicians better predict outcomes for individuals with pulmonary embolisms, says a Yale author of a new study.

Patients with acute pulmonary embolism can be selected for home management using the sPESI score or the Hestia criteria, according to results of the HOME-PE trial presented in a Hot Line session today ...

Therapy Development Specialists at Penumbra, Inc. To establish a PERT, the framework and implementation are based on your current available resources with consideration for future growth and ...

Pulmonary embolism (PE) remains a major cause of cardiovascular morbidity and mortality worldwide. It occurs when thrombotic material—most often ...

Rapidai Inc. Received U.S. FDA 510(k) clearance for Rapid RV/LV, the latest addition to its pulmonary embolism (PE) solution. Rapid RV/LV uses artificial intelligence to quickly calculate the right ...

Yale New Haven Hospital has become one of the first 12 hospitals in the world to be designated as a Pulmonary Embolism Comprehensive Care Center of Excellence. This marks a significant achievement in ...

CAMPBELL, Calif., September 02, 2025--(BUSINESS WIRE)--Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its Symphony ® Thrombectomy System to treat ...